Hot Stocks: Brokerages view on Trent, Nazara Technologies, Nestle and JB Pharma

Citigroup maintained a buy rating on Nestle India post Q3 results with a target price of Rs 2900. The company reported steady revenue growth and guided for a margin expansion in Q4CY23, it said.

More To Explore